U.S., Sept. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07170566) titled 'A Retrospective, Observational Study of the Real-world Safety and Performance of InnovaMatrix(R) AC at a Single Centre' on Aug. 21.
Brief Summary: The use of a decellularised porcine placental extracellular matrix in hard-to-heal wounds: A retrospective study of the real-world performance of InnovaMatrix(R) AC at a single centre.
Study Start Date: May 01, 2024
Study Type: OBSERVATIONAL
Condition:
Wound Heal
Intervention:
DEVICE: innovaMatrix AC
nnovaMatrix(R) AC consists of ECM derived from porcine placental material. The device is supplied in a variety of sterile sheet configurations. It is packaged in double peel-open pack...